Alera Investment Advisors, LLC Eli Lilly & CO Transaction History

Alera Investment Advisors, LLC

$838 Million
Q3 2024

A detailed history of Alera Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alera Investment Advisors, LLC holds 3,041 shares of LLY stock, worth $2.27 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

3,041

Previous 2,724 11.64%

Holding current value

$2.27 Million

Previous $2.47 Million 9.25%

% of portfolio

0.32%

Previous 0.3%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $244,768 - $304,326	317 Added 11.64%	3,041 $2.69 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $985,098 - $1.24 Million	1,359 Added 99.56%	2,724 $2.47 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $812,498 - $1.09 Million	-1,372 Reduced 50.13%	1,365 $1.06 Million
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $102,937 - $121,349	-196 Reduced 6.68%	2,737 $1.6 Million
Q3 2023 Oct 11, 2023	SELL	$434.7 - $599.3 $54,337 - $74,912	-125 Reduced 4.09%	2,933 $1.58 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $350 - $468	-1 Reduced 0.03%	3,058 $1.43 Million
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $92,878 - $109,081	-299 Reduced 8.9%	3,059 $1.05 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $45,017 - $52,453	-140 Reduced 4.0%	3,358 $1.23 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $5,336 - $6,081	-18 Reduced 0.51%	3,498 $1.13 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $13,936 - $16,363	50 Added 1.44%	3,516 $1.14 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $382,544 - $475,405	1,630 Added 88.78%	3,466 $993,000
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $129,738 - $161,006	-577 Reduced 23.91%	1,836 $507,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $411,068 - $505,877	1,855 Added 332.44%	2,413 $558,000
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $411,068 - $505,877	-1,855 Reduced 76.88%	558 $558,000
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $9,208 - $11,910	51 Added 2.16%	2,413 $554,000
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $56,361 - $72,962	-343 Reduced 12.68%	2,362 $441,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $14,741 - $19,507	113 Added 4.36%	2,705 $457,000
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $77,204 - $89,300	528 Added 25.58%	2,592 $384,000
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $7,619 - $9,430	64 Added 3.2%	2,064 $286,000
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $46,724 - $57,871	-437 Reduced 17.93%	2,000 $263,000
Q3 2019 Oct 25, 2019	BUY	$106.79 - $116.16 $5,873 - $6,388	55 Added 2.31%	2,437 $273,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $9,417 - $10,992	-85 Reduced 3.45%	2,382 $264,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $6,344 - $7,468	57 Added 2.37%	2,467 $320,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $255,219 - $285,922	2,410 New	2,410 $279,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alera Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alera Investment Advisors, LLC with notifications on news.

Account

Alera Investment Advisors, LLC Eli Lilly & CO Transaction History